News
Leerink Partners Initiates Coverage On AnaptysBio with Outperform Rating, Announces Price Target of $47
16 Apr 24
News, Price Target, Initiation, Analyst Ratings
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
11 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
11 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Wells Fargo Initiates Coverage On AnaptysBio with Overweight Rating, Announces Price Target of $56
11 Apr 24
News, Price Target, Initiation, Analyst Ratings
Unveiling 4 Analyst Insights On AnaptysBio
1 Apr 24
Analyst Ratings
JP Morgan Maintains Neutral on AnaptysBio, Lowers Price Target to $28
1 Apr 24
News, Price Target, Analyst Ratings
Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers
12 Mar 24
Analyst Color, Biotech, Earnings, News, Upgrades, Health Care, Analyst Ratings, Movers, Trading Ideas, General
Wedbush Upgrades AnaptysBio to Outperform
12 Mar 24
News, Upgrades, Analyst Ratings
AnaptysBio Q4 EPS $(1.59) Beats $(1.60) Estimate, Sales $9.01M Beat $2.23M Estimate
11 Mar 24
Earnings, News
Stifel Initiates Coverage On AnaptysBio with Buy Rating, Announces Price Target of $50
21 Feb 24
News, Price Target, Initiation, Analyst Ratings
Press releases
Actym Therapeutics Appoints Thomas Smart as CEO
24 Apr 24
Press Releases
Anaptys to Present at TD Cowen's 44th Annual Health Care Conference and 2024 AAD Annual Meeting
29 Feb 24
News, Press Releases
Anaptys to Present at Guggenheim's 6th Annual Biotechnology Conference
31 Jan 24
News, Press Releases